Researchers at the University of Michigan's C.S. Mott Children's Hospital have identified a promising new target for developing new therapies for kids with high-risk neuroblastoma, according to a new study published in Molecular Cancer Research.
from The Medical News http://ift.tt/1CSd3oW
from The Medical News http://ift.tt/1CSd3oW
No comments:
Post a Comment